Results 51 to 60 of about 35,888 (296)

Buprenorphine-Containing Medications for the Treatment of Opioid Use Disorder in Primary Care [PDF]

, 2022
The opioid epidemic has undoubtedly become a major problem across the United States. Whether it is in primary care, emergency services, or inpatient hospitalization, every healthcare worker witnesses the effects of opioid use disorder. Pharmacotherapy is
Scherer, Shannon
core  

Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study

Addiction Science & Clinical Practice, 2023
Background Medications for opioid use disorder (MOUD) are associated with positive health outcomes. People remaining on MOUD have a reduced likelihood of drug overdose and mortality.
Deja Knight, Iddi Haruna Nkya, Nora Solon West, Cui Yang, Michael Kidorf, Carl Latkin, Haneefa T. Saleem   +6 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Influences on advance practice nursing education to prescribe medications for opioid use disorder [PDF]

, 2023
BACKGROUND: Opioid misuse is a major public health concern in the United States. Opioid agonist medications are evidence-based treatments for opioid use disorders (OUD) that can be prescribed by advance practice registered nurses (APRNs) with ...
Tierney, Matthew, Joanne Spetz, Susan A. Chapman, Spetz, Joanne, Chapman, Susan A, Phoenix, Bethany J, Bethany J. Phoenix, Matthew Tierney   +7 more
core   +1 more source

Antibiotic therapy completion for injection drug use-associated infective endocarditis at a center with routine addiction medicine consultation: a retrospective cohort study

BMC Infectious Diseases, 2022
Background Addiction medicine consultation and medications for opioid use disorder are shown to improve outcomes for patients hospitalized with infective endocarditis associated with injection drug use.
Muhammad Dhanani, Courtney Goodrich, Janice Weinberg, Carlos Acuna-Villaorduna, Tamar F. Barlam   +4 more
doaj   +1 more source

Experiences Using a Multidisciplinary Model for Treating Injection Drug Use Associated Infections: A Qualitative Study

Frontiers in Psychiatry, 2022
BackgroundOver the past two decades, the United States has experienced a dramatic increase in the rate of injection drug use, injection associated infections, and overdose mortality. A hospital-based program for treating opioid use disorder in people who
Nathanial S. Nolan, Emily Gleason, Laura R. Marks, Tracey Habrock-Bach, Stephen Y. Liang, Stephen Y. Liang, Michael J. Durkin   +6 more
doaj   +1 more source

Opioid use Disorder for Prescription Opioid Medications

Global Journal of Addiction & Rehabilitation Medicine, 2017
Why are opioid medications prescribed in large quantities and high frequency when there is little or no proven efficacy for their therapeutic value? Why are opioids the most commonly prescribed medication in the United States for the past decades when the adverse consequences continue to grow and mount?
openaire   +1 more source

Initiating buprenorphine in New Jersey emergency departments: a mixed methods study

JEM Reports
Background: Emergency departments (EDs) represent a critical touchpoint in the treatment of opioid use disorder (OUD), yet evidence-based practices such as buprenorphine initiation have not been widely adopted. Objectives: This study describes state-wide
Cadence F. Bowden, Peter Treitler, Jennifer Miles, Hannah Shepherd, Kylie Davidson, Stephen Crystal   +5 more
doaj   +1 more source

Mind the gap: a quality improvement study to determine health care value of rapid-access telemedicine addiction treatment in recently incarcerated individuals

BMC Health Services Research
Background Previously incarcerated individuals experience a significant and vulnerable time post-release, highlighted by a greater than 129 times higher risk of overdose death.
John Golden, Divya Venkat, Yue Yin, Thomas Robertson   +3 more
doaj   +1 more source

Clinical Impact of an Expanded MOUD Access Initiative for Patients Hospitalized With Infections From Intravenous Opioid Use

American Journal of Medicine Open
Background: Despite their efficacy, medications for opioid use disorder (MOUD) remain underutilized in patients with infections from intravenous opioid use (I-IOU).
Jack Keegan, William Peppard, Rebecca Bauer, Mary Beth Alvarez, Kimberly Stoner, Jennifer McNeely   +5 more
doaj   +1 more source